Issued Patents 2018
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10138248 | Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors | Andrew W. Buesking, Richard B. Sparks, Brent Douty, Nikoo Falahatpisheh, Lixin Shao +2 more | 2018-11-27 |
| 10092570 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Eddy W. Yue, Song Mei, Wenyu Zhu +5 more | 2018-10-09 |
| 10077277 | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors | Yun-Long Li | 2018-09-18 |
| 10065963 | Heterocyclic compounds as PI3K-γ inhibitors | Artem Shvartsbart, Stacey Shepard, Lixin Shao, Nikoo Falahatpisheh, Ge Zou +2 more | 2018-09-04 |
| 10034864 | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | Eddy W. Yue, Richard B. Sparks, Wenyu Zhu | 2018-07-31 |
| 10022387 | Aza-heteroaryl compounds as PI3K-gamma inhibitors | Ge Zou, Andrew W. Buesking | 2018-07-17 |
| 9975907 | Pyrimidinones as PI3K inhibitors | Yun-Long Li, Brian W. Metcalf | 2018-05-22 |
| 9957268 | 1H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | Thomas P. Maduskuie, Jr., Nikoo Falahatpisheh | 2018-05-01 |
| 9944646 | Bicyclic azaheterocyclobenzylamines as PI3K inhibitors | Richard B. Sparks, Thomas P. Maduskuie, Jr. | 2018-04-17 |
| 9938294 | Tricyclic heterocycles as BET protein inhibitors | Richard B. Sparks, Thomas P. Maduskuie, Jr., James D. Rodgers | 2018-04-10 |
| 9932341 | Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders | Yun-Long Li, Eddy W. Yue, Song Mei, Brent Douty | 2018-04-03 |
| 9918990 | Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors | Eddy W. Yue, Brent Douty | 2018-03-20 |
| 9879010 | Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b] pyrimidin-5-yl-amines as Janus kinase inhibitors | James D. Rodgers, Haisheng Wang, Richard B. Sparks | 2018-01-30 |